Syncona (LSE:SYNC) Insider Ownership : 0.69 % (As of May. 25, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Syncona Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Syncona's insider ownership is 0.69%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Syncona's Institutional Ownership is 31.30%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Syncona's Float Percentage Of Total Shares Outstanding is 0.00%.

Syncona Insider Ownership Historical Data

The historical data trend for Syncona's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncona Insider Ownership Chart

Syncona Historical Data

The historical data trend for Syncona can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Insider Ownership	0.67	0.67	0.67	0.67	0.67	0.68	0.68	0.68	0.69	0.69

Syncona Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Syncona (LSE:SYNC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Syncona Ltd (LSE:SYNC) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

SYNCl:UK

Address

8 Bloomsbury Street, 2nd Floor, London, GBR, WC1B 3SR

Website

https://www.synconaltd.com

Syncona Ltd is a closed-ended investment company in the United Kingdom. Its investment objective is to achieve superior long-term capital appreciation from its investments. The company invests in life science businesses (including private and quoted companies) and single or multi-asset projects (Life Science Investments).